Xenon Pharmaceuticals Inc. · NASDAQ:XENE

Kelly Thomas Patrick exercised options for 7,500 Xenon Pharmaceuticals Inc. shares (Form 4)

Traded Oct 15, 2026 · Filed Oct 16, 2026

On Oct 15, 2026, Kelly Thomas Patrick (Chief Financial Officer) exercised options for 7,500 Xenon Pharmaceuticals Inc. shares, leaving 22,500 shares. Filed Oct 16, 2026 (Form 4).

Options exercised
7,500 shares
Holding after
22,500 shares
Trading plan
No
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 15, 2026Common SharesOption exercise7,50022,500Direct

Source

Download original · View original at SEC

Related